Population growth and changes in demographic structure are linked to trends in colorectal cancer (CRC) incidence. The aim of this study is to estimate future CRC incidence in the ageing population, and compare trends across developing and developed regions.
See editorials on pages 901 and 910; see similar article on page 903. I ncreasing life expectancy over the past decades has been a remarkable achievement, but is also posing greater challenges to global health, 1,2 notably due to increased cancer incidence among the elderly. Cancer is one of the most important life-threatening diseases and is more prevalent in the elderly. There are many factors contributing to these higher incidences, especially the total population growth and the change of demographic structure. 2 Overall cancer incidence rates in developing countries are lower than those seen in developed countries. However, the survival time of these patients with cancer is commonly shorter in developing countries because of the delayed diagnosis or limited access to advanced treatment.
show steady trends of age-standardized incidence rates over a projection period to 2030, crude incidence rates are projected to increase from 30% to 50% in the same period as a result of increased elderly population. 5, 6 It is important to predict the future cancer burden so that policy makers can better utilize constrained healthcare resources.
Several previous studies projected the future trends of cancer incidence. [7] [8] [9] [10] [11] [12] [13] Age-standardized incidence rates are often used to compare the trends of cancer incidence across countries. 14 In fact, population growth and change of population demographic structure are the driving forces to increase cancer incidence. The current study focuses on the change of population structure among the ageing population in various regions (east vs west, and developed vs developing) and makes future projections of CRC incidence for cross-regional comparison. We believe that these projections provide insight and help predict the healthcare workload and financial burden on the healthcare systems in different jurisdictions.
Methods

Data Extraction
Cancer incidence data and population statistics were extracted from the International Agency for Research on Cancer in World Health Organization. 15 Annual incidence rates for cancer in 118 selected populations were extracted from 102 cancer registries in 39 countries worldwide. We targeted the jurisdictions that report the cancer incidence since 1988, and used 20-year historical data to project the cancer trends up to 2030. We selected the regions with the following priorities: jurisdictions with national registry were preferred, otherwise regional cancer registries would be combined; and the population and cancer statistics in the selected jurisdictions were available online and reported in English. We selected at least 1 developing and 1 developed jurisdiction in the United States, Europe, and Asia for global comparison.
In this study, jurisdictions with high-income economies were categorized as developed countries, whereas emerging regions from low-or middle-income economies were categorized as developing countries. The economic levels were classified with the World Bank Atlas method with adjustment for exchange rate and local and international inflation: low-income economies are defined as those with a gross national income per capita of $545 or less in 1988 and $935 or less in 2007; high-income economies are those with a gross national income per capita of $6000 or more in 1988 and $11,455 or more in 2007; middle-income economies are defined as those between low-and high-income economies. 16 Gross domestic product of the selected jurisdictions was also reported for comparison. Although Shanghai may be regarded as a well-developed region, it changed from lowincome economy in 1990s to middle-income economy in 2000s. Therefore, according to the study timeframe, Shanghai was not classified as a developed jurisdiction.
Statistical Analysis
Projection models were conducted independently by sex and age groups according to the original data structure of the International Agency for Research on Cancer. Cancer incidence and population were the projection parameters. The conceptual framework is presented in Figure 1 . Time Figure 1 . Conceptual framework to estimate the age-standard incidence rate, incidence rate of age 65þ, and age-adjusted incidence rate. IARC, International Agency for Research on Cancer.
series in different autoregressive integrated moving average models were constructed to project cancer incidence and population with the 20-year cancer incidence rates from 1988 and projected to 2030. The KwiatkowskiPhillips-Schmidt-Shin test and Akaike Information Criterion values were used to determine the model validity. When the P value of Kwiatkowski-Phillips-Schmidt-Shin was > .05, this represented that data fulfill the assumption of stationary trend, 17 and the model with minimum Akaike Information Criterion value was selected as the best-fitted model. Otherwise, a linear regression model without autoregressive and moving average functions was applied. Cancer incidence rates were combined in each projected year and plotted against time. Because the projection parameters were presented in 5-year intervals by the International Agency for Research on Cancer, local polynomial regression was used to smooth the projection across the intervals. 18 The trends of incidence rates of age 65þ were further weighted by the increased elderly population (ie, a ratio of increased 65þ population in 1988), and this incidence rate was defined as an "ageadjusted incidence rate" for cross-regional comparison ( Figure 1 ). The projected cancer incidence and populations were compared with regional public statistics between 2008 and 2014 for validation (Supplementary Table 1 ).
All incidence rates were calculated as cases per 100,000 persons and plotted to project until 2030 using statistical software R version 3.2.1 (Bell Laboratories, Lucent Technologies, Murray Hill, NJ). Because the estimations of incidence rates are composed of many autoregressive integrated moving average models by sex and age groups, the Monte Carlo method was used to generate the 95% confidence intervals with reference to the projected means and variances of the cancer incidence and population from autoregressive integrated moving average models.
Results
Demographics of the Jurisdictions
A total of 77 of 102 cancer registries (75.5%) provided 20-year historical cancer incidence data, including 66 registries from developed and 11 registries from developing regions. A total of 8 jurisdictions in the United States, Europe, and Asia were selected according to our selection priority, including the United States (cancer registries from 11 sites), Costa Rica, the United Kingdom (7 sites), Sweden, Croatia, Japan (3 sites), Hong Kong, and China (Shanghai) ( Figure 2 ). Costa Rica, Croatia, and China (Shanghai) were classified as developing regions according to World Bank definitions ( Table 1) . The total population of 65þ in these jurisdictions was 12,917,794 in 1988, and increased to 17,950,115 in 2007. Those 65þ increased by almost 40% in the 20-year period. In Costa Rica, Shanghai, and Hong Kong, the population of 65þ was almost doubled. In Shanghai, gross domestic product per capita increased almost 10 times.
Trends of Colorectal Cancer With or Without Ageing Effect in United Kingdom
To distinguish the difference among the agestandardized incidence rates, the incidence rates of age 65þ, and the age-adjusted incidence rates of age 65þ, the UK figures were presented as a demonstration ( Figure 3 ). The age-standardized incidence rates were plotted within the range between 35/100,000 and 37/ 100,000 (black line). When only the population of age 65þ is considered, the CRC incidence rates increased about 7.5-fold to 269/100,000 in 1988 and fluctuated throughout the time period (solid green line). No obvious trend was observed over the 20 years of time. When the relative ratio of 65þ was fitted into the incidence rates, the age-adjusted incidence rate showed an increasing trend and was raised to 302/100,000 in 2007. 
Trends of Colorectal Cancer Across Other Regions
In 1988, the United States showed the highest CRC incidence rates for those aged 65þ among all jurisdictions (ie, 323/100,000), with the incidence continuing to fall ( Figure 4A ). In 2007, the rate of aged 65þ dropped to 238/ 100,000. The proportion of population aged 65þ only increased from 11.2% in 1988 to 11.4% in 2007. The age structure remained almost the same, implying that Figure 4 . (A) Incidence rates of age 65þ (left) and age-adjusted incidence rates (right) from 1988 to 2007. (B) Projections of incidence rates of age 65þ (left) and age-adjusted incidence rates (right).
adjusted incidence rates for the change of elderly population showed a similar downward trend to 243/100,000 (20-year change of CRC incidence rate, À25.0%) ( Figure 4B, Supplementary Table 3 ). In the United Kingdom, the incidence of CRC was relatively stable for those aged 65þ across the years. The age-adjusted incidence rates ranged from 269/100,000 in 1988 to 302/100,000 in 2007 (20-year change of CRC incidence rate, 12.4%). The trends for adjusted incidence rates of age 65þ were comparable with that of Sweden. However, a different picture emerged from Hong Kong and Japan, which demonstrated the largest increase in CRC incidence rates in this same period. In Hong Kong, the overall incidence rate increased from 219/100,000 in 1988 to 298/ 100,000 in 2007. The proportion of the population aged 65þ increased from 8% to 12.6%, so the age-adjusted incidence rate escalated to 464/100,000 by 2007 (20-year change of CRC incidence rate, 112%). In Japan, the incidence rate increased from 187/100,000 in 1988 to 252/100,000 in 2007. As the population of aged 65þ increased about 2-fold to 20.7% in 2007, the adjusted incidence rate for their aging populations escalated to 521/100,000 (20-year change of CRC incidence rate, 179%).
In the developing jurisdictions of Costa Rica, Croatia, and China (Shanghai), the increasing trends of incidence rates of those aged 65þ is remarkable ( Figure 4B, left) . Costa Rica showed more than a 2-fold increase in incidence rates among those aged 65þ, increasing from 57/ 100,000 in 1988 to 125/100,000 in 2007. The proportion of those aged 65þ increased from 4.6% in 1988 to 6.1% in 2007, with the result that the age-adjusted incidence rate of age 65þ increased to 165/100,000 in 2007 (20-year change of CRC incidence rate, 191%) ( Figure 4B, right, Supplementary Table 3 ). In Croatia, incidence rates for those aged 65þ showed a marked increase from 143/100,000 in 1988 to 265/100,000 in 2007. As the proportion of those aged 65þ increased from 11.8% in 1988 to 17.2% in 2007, so too did the age-adjusted incidence rate escalate to 386/100,000 in 2007 (20-year change of CRC incidence rate, 170%). In China (Shanghai), CRC incidence rates in those aged 65þ increased from 110/100,000 in 1988 to 231/ 100,000 in 2007. The proportion for those aged 65þ increased from 9.7% in 1988 to 15.3% in 2007, and the age-adjusted incidence rate increased by 3-fold to 364/100,000 in 2007 (20-year change of CRC incidence rate, 231%).
Projection of Colorectal Cancer Incidence Rates
The incidence rates of those aged 65þ and the ageadjusted incidence rates were projected to 2030. The United States showed decreasing trends for both incidence rates, whereas other jurisdictions showed increasing trends ( Figure 4B ). The projected figures for CRC incidence rates and the changes of age structure are presented in Table 2 . In China (Shanghai), Costa Rica, and Croatia, increasing trends of CRC incidence rates were observed. China (Shanghai) shows the fastest increasing trend of incidence rates for those aged 65þ, increasing from 110/ 100,000 in 1988 to 311/100,000 in 2030. With the expected ageing population, the age-adjusted incidence rates projected to 805/100,000 by 2030. Although Japan and Hong Kong showed moderate increasing trends of CRC during the historical period, the future projection of incidence in Japan will increase more rapidly than that in Hong Kong. Validations with the regional government statistics on cancer and population were conducted. Reported statistics on cancer incidence and populations were available in 6 of the 8 jurisdictions (Supplementary Table 1 ). Cancer incidence rates for those aged 65þ were piloted with our projection between 2007 and 2014 (Supplementary Figure 1) . Most of the jurisdictions showed comparable trends to the projection models.
Change of Ranking on Colorectal Cancer Incidence Rates
Among the jurisdictions included in this study, United States and United Kingdom started with the highest cancer incidence rates of 65þ in 1988. However, with the projected incidence related to change in age structure, the United States will have the lowest incidence rates by 2030 (Figure 3 ). Croatia will have the highest incidence rates of age 65þ in 2030. After adjusting for the change of age structure, Japan and China (Shanghai) are expected to be the top-ranked regions.
Discussion
This study compared the future trends of CRC in the ageing population. The incidence of CRC is predicted to increase because of population growth and ageing. Across the developed and developing regions, all but the United States showed moderate or even rapid increasing trends of CRC.
According to global cancer statistics, 2 overall cancer incidence rates in developing regions are approximately one-half those seen in the developed regions. The overall cancer incidence was summarized as age-standardized incidence rates that included young generations.
14 In a recent study on the global burden of cancer, 3 the agestandardized incidence rates for CRC were shown to be lower in developing countries between 1990 and 2013. Our analysis suggests that the CRC incidence in some developing regions will increase much faster than that in the developed regions in the coming decades, putting pressure on already stretched health systems. The global disease studies also showed that the historical growth in CRC cases was caused by the change in age structure (41.5%), population size (35%), and incidence rate (15.7%). 3 Our study focused on the change of age structure and the ageing population growth. If only the change of population size is considered, the countries with large populations, such as China, must be the most critical regions. A US study focused on the change of population growth in the projection model, and projected an increasing trend of CRC incidence until 2030. 9 With CRC incidence trends compared across the jurisdictions, our study showed that CRC incidence rates are only falling in the United States. Early initiation of CRC screening may be the reason for this downward trend. Screening for CRC has been conducted in the United States since the 1980s, and has been demonstrated to be effective to reduce the cancer incidence and mortality. [19] [20] [21] [22] [23] However, our findings showed that the overall CRC incidence has dropped since the mid-1970s, before the initiation of population-wide screening programs. A recent publication discussed this phenomenon and suggested that the discovery of the association between colonic polypectomy and CRC by Gilbertsen et al in 1965 might be a driving force for the decline. 24, 25 Decreased consumption of smoked or cured meat, and increased use of antibiotics and nonsteroidal anti-inflammatory drugs were also suggested as CRC reduction factors. Another influence might be the reduction of the smoking population. Smoking has been reported as a risk factor of CRC, 26 although the prevalence of smoking peaked during the 1950-1970s and declined afterward. 27, 28 Unfortunately, initiating cancer screening in developing countries is hindered by the lack of financial and manpower resources. Even in some developed regions, such as Hong Kong, strategies for national-based screening programs remain undecided (Supplementary  Table 2 ). Because risk and benefit vary among individuals, adjusting screening method and time based on personal risk level has been proposed in different regions. [29] [30] [31] [32] [33] [34] According to the US Preventive Services Task Force, screening for CRC in subjects older than 85 years is not recommended. 34 There are other methods for cancer incidence projection, such as the age-period-cohort model and the average annual percentage change model. In the ageperiod-cohort model, the historical trends are divided into age, period, and cohort effects. The screening uptake after a public campaign can be regarded as the period effect, and the population with the same birth year is treated as the cohort effect. The age-period-cohort model would require several assumptions regarding the period and cohort effects in the projection models across the regions, and was not adopted for our study. In the average annual percentage change model, the trends are fitted by joinpoint regressions. This is a method to compute trends in segments, combined with different weighted joinpoint regression lines. The projected trends are log-linear estimates. We ultimately used time series models, which evaluated time-dependent trends with consideration of seasonal patterns. We also utilized regression methods when the model validity in the time series method was violated. Therefore, our methodology can be considered a combined approach to project cancer incidence.
Validation is important to demonstrate the accuracy of projection results, so we compared the projection results with the regional reported statistics between 2007 and 2014. Most of the jurisdictions showed comparable trends to the projection models, except the United States. The actual US figures showed a faster decreasing trend than we expected, because the projected cancer incidence was higher and the projected population was lower than the actual values from the public statistics.
A strength of this study is the inclusion of large datasets to demonstrate the trends of cancer incidence. However, there are several limitations. First, this study analyzed secondary sources in which the data quality cannot be guaranteed, so we validated our projection with recent statistics. The longer projection may lead to less accurate estimation, but all regions were estimated by the same methodology for comparison. Second, the study only focused on the proportion of the population aged 65þ. We observed that approximately 30% of CRC occurred before the age of 65 from the year 1988 to 2007, but this ratio did not change over the years. If more CRC occurs in younger generations, the current projection of CRC may be overestimated. Third, the available cancer registries are limited in some countries. For example, the cancer data from Shanghai only included 9 out of 16 towns representing one-half of the total population in the city. Fourth, the cancer incidence and population statistics were only reported until 2007 at the time of analysis. The projection to 2030 may be optimistic. It is worth updating the result when the World Health Organization reports the most recent figures. Finally, although the incidence rates were adjusted for age and sex, the future trends were still affected by other factors, such as the acceptance of cancer screening and the change of lifestyle. Some of these factors may have short-term impact on early detection of CRC, and reduce the long-term incidence. Also, the CRC mortality trend was not assessed in this study because the cancer survival rate improves over time along with enhancement of chemotherapy and surgical techniques.
In conclusion, incidence of CRC will continue to rise in future decades because of the changes in age structure and population growth. The future burden of CRC will be heavier in developing regions where health systems are more fragile and require substantial resources to meet the needs of their populations. Because CRC is a preventable disease, lifestyle modification and screening for CRC are necessary.
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